34881-44-2

Usage

Uses

Used in Pharmaceutical Industry:
1-Bromo-2-ethyl-4-methoxy-benzene is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 1-Bromo-2-ethyl-4-methoxy-benzene is utilized as an intermediate in the production of agrochemicals, contributing to the development of effective pest control agents and other agricultural products.
Used in Dye Production:
1-Bromo-2-ethyl-4-methoxy-benzene is employed as a key component in the synthesis of dyes, enabling the creation of a wide range of colorants for various applications, including textiles, plastics, and printing inks.
Used in Perfume Industry:
This organic compound is also used in the perfume industry as a precursor for the production of fragrances, adding to the complexity and variety of scents in perfumes and other scented products.
Used in Organic Compounds Synthesis:
1-Bromo-2-ethyl-4-methoxy-benzene serves as a building block in the synthesis of other organic compounds, expanding the scope of chemical research and development in various industries.

Upstream product

• 10568-38-4 3-ethylanisole 
• 139469-06-0 1-bromo-5-dimethoxy-2-vinylbenzene 

Downstream Products

• 378787-51-0 1-butoxy-2-ethyl-4-methoxybenzene 
• 342899-07-4 (2-ethyl-4-methoxy)phenylboronic acid 
• 1417742-26-7 (2-ethyl-4-methoxyphenyl)dimethylsilane 
• 864359-23-9 4-(2-Ethyl-4-methoxy-phenyl)-piperazine-1-carboxylic acid tert-butyl ester 

Relevant academic research and scientific papers

Eleven amino acid glucagon-like peptide-1 receptor agonists with antidiabetic activity

Glucagon-like peptide 1 (GLP-1) is a 30 or 31 amino acid peptide hormone that contributes to the physiological regulation of glucose homeostasis and food intake. Herein, we report the discovery of a novel class of 11 amino acidGLP-1 receptor agonists. These peptides consist of a structurally optimized 9- mer, which is closely related to the N-terminal 9 amino acids ofGLP-1, linked to a substituted C-terminal biphenylalanine (BIP) dipeptide. SAR studies resulted in 11-mer GLP-1R agonists with similar in vitro potency to the native 30-mer. Peptides 21 and 22 acutely reduced plasma glucose excursions and increased plasma insulin concentrations in a mouse model of diabetes. These peptides also showed sustained exposures over several hours in mouse and dog models. The described 11-mer GLP-1 receptor agonists represent a new tool in further understanding GLP-1 receptor pharmacology that may lead to novel antidiabetic agents.

Process for the preparation of amino acids useful in the preparation of peptide receptor modulators

The present invention provides process useful for the preparation of intermediates which are useful in the preparation of amino acids useful in preparing peptide receptor modulators, for example agonists or partial agonists of such peptide receptors. Such

A Mild Selective Monobromination Reagent System for Alkoxybenzenes; N-Bromosuccinimide-Silica Gel

The monobromination of alkoxybenzenes with N-bromosuccinimide catalyzed by silica gel in carbon tetrachloride occurred preferentially at the para-position. m-t-Butylmethoxybenzene yielded 4-bromo-3-t-butyl-1-methoxybenzene with a selectivity of 74percent even in the presence of a bulky substituent at the meta-position.